Evidence map›Paper›PMID 40837542›Full record

ArticleJHLT open2025

Stroke in pediatric ventricular assist device support.

Christina VanderPluym, Ryan Kobayashi, Michael Rivkin

Abstract read
In one paragraph

Article in JHLT open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christina VanderPluymHeart Center, Boston Children's Hospital, Harvard School of Medicine, Boston, MA.
Ryan KobayashiHeart Center, Boston Children's Hospital, Harvard School of Medicine, Boston, MA.
Michael RivkinDepartment of Neurology, Boston Children's Hospital, Harvard School od Medicine, Boston, MA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke continues to be one of the most significant hemocompatibility related adverse event in pediatric ventricular assist device support. Tremendous gains have been made in reducing the incidence of stroke across all ages, diagnoses and device types. However there still remains noticeable differences in the hemocompatibility of device types, with paracorporeal continuous and pulsatile flow associated with higher rates of ischemic stroke as compared to intracorporeal devices. In this review article, we discuss the landscape of pediatric stroke in mechanical circulatory support focusing on; pathophysiology of stroke in this heightened risk population, past and present incidence of stroke, stroke diagnosis and acute stroke management.

Indexed as

Congenital heart diseaseHemorrhagic strokeIschemic strokePediatricVentricular assist device

Identifiers

PMID40837542
PMCPMC12362080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.